Siemens Siemens.com Siemens diagnostics.com
Search Our Knowledge Base
Physicians Laboratory Professionals Healthcare Administrators Patients
 
Home

Identification of a Structural Abnormality

Algorithm for the Diagnosis of Heart Failure 2

A complete history and physical examination are the first steps in evaluating the structural abnormality or cause responsible for the development of HF. Although the history and physical examination may provide important clues about the nature of the underlying cardiac abnormality, identification of the structural abnormality leading to HF generally requires either noninvasive or invasive imaging of the cardiac structures.1,2

The single most useful diagnostic test in the evaluation of patients with HF is the two-dimensional echocardiogram, coupled with Doppler flow studies. This test allows the physician to determine whether the primary abnormality is pericardial, myocardial or valvular and if myocardial, whether the dysfunction is primary systolic or diastolic. The measurement of left ventricular ejection fraction is the primary functional information gained from the echocardiogram. The hallmark of patients with predominant systolic dysfunction is a depressed left ventricular ejection fraction (generally less than 40%).1 It must be recognized, however, that the reproducibility of ejection fraction is poor, even when the same technicians are used.2 Further, echocardiography slots are limited and typically not available in many institutions 24 hours / 7 days a week.

Because it is not uncommon for a patient to have more than one cardiac abnormality that contributes to the development of HF, the echocardiogram provides additional value by allowing for the quantitative assessment of the dimensions, geometry, thickness, and regional motion of the right and left ventricles and the qualitative evaluation of the atria, pericardium, valves and vascular structures.1,2

Other tests may be used to provide information regarding the nature and severity of the cardiac abnormality:1,2

  • Radionuclide Ventriculography provides highly accurate measurements of global and regional functions, but it is unable to directly assess cardiac hypertrophy or valvular abnormalities.
  • Magnetic Resonance Imaging or Computed Tomography may help evaluate ventricular mass, detect right ventricular dysplasia or recognize the presence of pericardial disease. They are accurate and reproducible methods for the measurement of cardiac volumes, wall thicknesses and left ventricular mass. They also reliably detect thickened pericardium and quantitate myocardial necrosis, perfusion and function.2
  • Chest Radiography should be part of the initial diagnostic work-up in heart failure, because it is useful in detecting the presence of pulmonary disease or estimate the degree of cardiac enlargement or pulmonary congestion. Because of a low sensitivity and specificity, this test should not form the primary basis for determining the specific cardiac abnormality responsible for the development of HF.
  • 12-lead Electrocardiogram is helpful in demonstrating evidence of a prior MI, left ventricular hypertrophy or a cardiac arrhythmia. Because of a low sensitivity and specificity, this test should not form the primary basis for determining the specific cardiac abnormality responsible for the development of HF.

    Electrocardiographic changes in patients with HF are frequent. The negative predictive value of a normal ECG exceeds 90%. Conversely, the presence of anterior Q waves and a left bundle branch block in patients with ischemic heart disease are good predictors of a decreased ejection fraction.2

For more information, click on the following subjects:
Clinical Assessment of Patients with Heart Failure
Identification of a Structural Abnormality
Evaluating the Cause of Ventricular Dysfunction
The Role of Natriuretic Peptides

References

© Siemens Healthcare Diagnostics Inc. 2007-2008 | Corporate Information | Privacy Policy | Terms of Use | Home | What's New | Glossary | Contact Us | Site Map | Site Index